ArticleDiabetology & metabolic syndrome2020

Omarigliptin decreases inflammation and insulin resistance in a pleiotropic manner in patients with type 2 diabetes.

Sachiko HattoriPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.